Oral Abstract Session 500
8:00 am – 10:00am
RNA Virus Vectors I: Integration Profiles
(Abstracts 965-972)
Room 302
Co-Chairs
Luigi M. Naldini, MD, PhD
Noriyuki Kasahara, MD, PhD
Oral Abstract Session 501
8:00 am – 10:00am
Targeting and Molecular Strategies
(Abstracts 973-980)
Room 312
Co-Chairs
Todd Giorgio, PhD
Hideyoshi Harashima, PhD
Oral Abstract Session 502
8:00 am – 10:00am
Inborn Errors of Metabolism
(Abstracts 981-988)
Room 309
Co-Chairs
Markus Grompe, MD
Cary Harding, PhD
Oral Abstract Session 503
8:00 am – 10:00am
Neurologic – Novel Approaches
(Abstracts 989-996)
Room 311
Co-Chairs
David J. Fink, MD
Howard J. Federoff, MD, PhD
Oral Abstract Session 504
8:00 am – 10:00am
Muscle Gene Therapy: Systemic Delivery
(Abstracts 997-1004)
Room 208
Co-Chairs
Dongsheng Duan, PhD
Scott Q. Harper, PhD
Oral Abstract Session 505
8:00 am – 10:00am
Immunity and Tolerance to the Transgene Product
(Abstracts 1005-1012)
Room 204/206
Co-Chairs
Roland W. Herzog, PhD
Isabelle Riviere, PhD
Oral Abstract Session 506
8:00 am – 10:00am
RNA-based Gene Control & Technical Advances in Gene Regulation
(Abstracts 1013-1020)
Room 210
Co-Chairs
Robert E. Richard, MD, PhD
Ramesh Akkina, DVM, PhD
Oral Abstract Session 507
8:00 am – 10:00am
Oligonucleotide Therapies for Infectious Diseases and Inflammation
(Abstracts 1021-1028)
Room 100
Co-Chairs
Anton P. McCaffrey, PhD
Marco Weinberg, PhD
Oral Abstract Session 508
8:00 am – 10:00am
Pluripotent and Hematopoietic Stem Cells
(Abstracts 1029-1036)
Room 112
Co-Chairs
Karen E. Pollok, PhD
Donald B. Kohn, MD
11th Annual Meeting Concludes
10:00 am